General Updates

August 25, 2026 Listing Department Listing Department National Stock Exchange of India Limited BSE Limited Symbol: HONASA Scrip Code: 544014 Sub.: Update on proposed acquisition of Fluence Pharma Private Limited Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation of our earlier letter dated June 23, 2026 informing about proposed acquisition of 58% equity stake of Fluence Pharma Private Limited (“Fluence Pharma”) subject to completion of conditions precedent, we want to inform that the Company has today i.e. August 25, 2026 at 9:20 am (IST) called off the proposed acquisition of Fluence Pharma due to non-fulfilment of closing conditions specified under Share Purchase Agreement executed by Company and Fluence Pharma. The Company remains committed to its Nutraceutical strategy and will continue to evaluate the right opportunities, organic and inorganic, to build a strong consumer-focused business in this category. Kindly take the same on record. This disclosure will also be hosted on the Company's website viz. www.honasa.in. Thanking you, Yours truly, For Honasa Consumer Limited Gaurav Pandit Company Secretary and Compliance Officer Honasa Consumer Limited Registered Office: Unit No - 404, 4th Floor, City Centre, Plot No 05, Sector-12, Dwarka, New Delhi - 110075 Corporate Office: 10th & 11th Floor, Capital Cyberscape, Sector-59, Gurugram, Haryana - 122102 Email: info@mamaearth.in; Phone: 011 - 44123544 | Website: www.honasa.in | CIN: L74999DL2016PLC306016 |